Phototherapy and Photobiology — MCQs

Q: Which of the following is NOT a complication of PUVA therapy?

Exfoliative dermatitis. **Explanation:** PUVA (Psoralen + Ultraviolet A) therapy involves the administration of a photosensitizer (8-methoxypsoralen) followed by exposure to UVA radiation. While it is an effective treatment for conditions like psoriasis and vitiligo, it carries specific long-term and short-term risks. **Why Exfoliative Dermatitis is the correct answer:** Exfoliative dermatitis (Erythroderma) is **not** a direct complication of PUVA. In fact, PUVA is often used as a *treatment* modality for certain types of exfoliative dermatitis, such as those caused by Mycosis Fungoides or Psoriasis. While PUVA can cause a "PUVA itch" or a phototoxic burn (erythema), it does not typically trigger generalized exfoliation. **Analysis of Incorrect Options:** * **Premature aging of the skin (Dermatoheliosis):** Chronic UVA exposure leads to the degradation of collagen and elastin fibers, resulting in wrinkles, lentigines, and telangiectasia. * **Cataracts:** Psoralens distribute to the lens of the eye. If the eyes are not protected with UVA-blocking sunglasses for 24 hours post-ingestion, UVA exposure can lead to lens opacification. * **Skin cancers:** PUVA is mutagenic. Long-term therapy significantly increases the risk of Non-Melanoma Skin Cancers (NMSC), particularly **Squamous Cell Carcinoma (SCC)**. **High-Yield Clinical Pearls for NEET-PG:** * **Most common acute side effect:** Erythema (phototoxicity) and pruritus. * **Most common long-term risk:** Squamous Cell Carcinoma (SCC) is more common than Basal Cell Carcinoma (BCC) in PUVA patients (reversing the usual ratio). * **PUVA Lentigines:** Distinctive, irregular pigmented macules that appear after chronic therapy. * **Contraindications:** Pregnancy, lactation, history of skin cancer (Xeroderma Pigmentosum), and severe hepatic/renal failure.

Q: A 12-year-old boy, after spending his holiday on a beach, develops pruritic hemorrhagic vesicles on his cheeks, ears, nose, and hands 12 hours after sun exposure. A week later, the lesions crusted and healed with permanent scars. What is the most probable diagnosis?

Hydroa vacciniforme. **Explanation:** The clinical presentation of a young boy with **hemorrhagic vesicles** on sun-exposed areas (cheeks, ears, nose, hands) that heal with **permanent scarring** (varioliform scars) is pathognomonic for **Hydroa vacciniforme (HV)**. **Why Hydroa vacciniforme is correct:** HV is a rare, chronic photodermatosis primarily affecting children. It is triggered by UVA radiation. The hallmark is the progression from erythema to vesicles/bullae, which become umbilicated and hemorrhagic, eventually forming necrotic crusts. The defining feature for NEET-PG is the healing process, which results in **depressed, "vacciniform" (smallpox-like) scars**. It is often associated with **Epstein-Barr Virus (EBV)** infection. **Why other options are incorrect:** * **Polymorphic Light Eruption (PMLE):** The most common photodermatosis. While it causes pruritic papules or vesicles, it **never heals with scarring**. * **Actinic Prurigo:** A variant of PMLE common in Native Americans. It presents with intensely pruritic, excoriated papules and nodules, often involving the lips (cheilitis) and conjunctiva, but does not typically present with hemorrhagic vesicles and varioliform scarring. * **Persistent Light Reaction:** Now classified under Chronic Actinic Dermatitis. It is an eczematous reaction seen in elderly males, where skin remains sensitive to light even without allergen exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Action Spectrum:** UVA is the primary trigger for HV. * **Association:** Severe, systemic cases of HV are linked to **EBV-associated T-cell lymphoproliferative disorders**. * **Differential Diagnosis:** Must be distinguished from Erythropoietic Protoporphyria (EPP), which presents with immediate burning pain and waxy scarring, but lacks the hemorrhagic bullae of HV. * **Management:** Strict photoprotection; severe cases may require antimalarials or immunosuppressants.

Q: Psoralen plus ultraviolet A (PUVA) therapy is useful in which of the following conditions?

All of the above. **Explanation:** **PUVA (Psoralen + UVA)** therapy involves the administration of a photosensitizing agent (8-Methoxypsoralen) followed by exposure to long-wave ultraviolet A light (320–400 nm). The mechanism involves the formation of DNA photo-adducts, which inhibit DNA synthesis and induce apoptosis of hyperproliferating cells and T-lymphocytes. **Why "All of the Above" is Correct:** * **Psoriasis:** PUVA is a classic treatment for moderate-to-severe plaque psoriasis. It reduces the rapid turnover of keratinocytes and suppresses the local cutaneous immune response. * **Vitiligo:** Psoralens stimulate the migration and proliferation of melanocytes from the hair follicle reservoir to the depigmented skin, promoting repigmentation. * **Mycosis Fungoides (MF):** As a cutaneous T-cell lymphoma, MF is highly sensitive to the phototoxic effects of PUVA, which induces apoptosis in malignant T-cells infiltrating the epidermis. **Clinical Pearls for NEET-PG:** 1. **Mechanism:** Psoralens intercalate into DNA; UVA then causes **Type I (oxygen-independent)** reactions forming monoadducts/cross-links and **Type II (oxygen-dependent)** reactions forming free radicals. 2. **Dosage:** Oral psoralen is usually given **0.6 mg/kg**, 2 hours before UVA exposure. 3. **Side Effects:** Acute side effects include nausea and erythema. Long-term risks include **PUVA lentigines** and an increased risk of **Squamous Cell Carcinoma (SCC)**. 4. **Contraindication:** PUVA is contraindicated in patients with Xeroderma Pigmentosum, Lupus Erythematosus, and pregnancy. 5. **Current Trend:** Narrowband UVB (311 nm) has largely replaced PUVA for psoriasis and vitiligo due to a better safety profile, but PUVA remains superior for thick plaques and MF.

Q: Psoralen is used in the treatment of:

Vitiligo. **Explanation:** **Psoralen** is a photosensitizing agent used in **PUVA (Psoralen + Ultraviolet A)** therapy. It belongs to the furocoumarin family and works by intercalating into DNA. Upon exposure to UVA light, it forms DNA cross-links, which inhibits keratinocyte proliferation and induces melanocyte stimulation. **Why Vitiligo is correct:** In Vitiligo, PUVA therapy is a classic treatment modality. It works by: 1. **Immunomodulation:** Suppressing the T-cell mediated destruction of melanocytes. 2. **Melanocyte Stimulation:** Promoting the migration of melanocytes from the hair follicle reservoir to the depigmented skin, leading to repigmentation. **Why other options are incorrect:** * **Pemphigus:** This is an autoimmune bullous disorder treated primarily with systemic corticosteroids and immunosuppressants (e.g., Rituximab, Azathioprine), not phototherapy. * **Pityriasis alba:** This is a mild form of dermatitis common in children, usually associated with atopy. It is treated with emollients and low-potency topical steroids; psoralens are not indicated. * **Ichthyosis:** This is a genetic disorder of keratinization characterized by fish-like scales. Treatment involves keratolytics (e.g., urea, lactic acid) and systemic retinoids. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Psoralens (e.g., 8-Methoxypsoralen) bind to pyrimidine bases (thymine) in DNA. * **Common Indications for PUVA:** Psoriasis (most common), Vitiligo, Mycosis Fungoides (CTCL), and Alopecia Areata. * **Side Effects:** Acute side effects include nausea and polymorphic light eruption. Long-term risks include **PUVA lentigines** and an increased risk of **Squamous Cell Carcinoma (SCC)**. * **Contraindication:** PUVA is contraindicated in patients with Xeroderma Pigmentosum, SLE, or a history of skin cancer.

Q: All of the following are true about solar urticaria EXCEPT:

Common in females between the age group of 20-40 years.. **Explanation:** Solar urticaria is a rare, IgE-mediated physical urticaria triggered by exposure to ultraviolet (UV) or visible light. **1. Why Option A is the correct answer (The Exception):** While solar urticaria can occur at any age, the peak incidence is actually in the **younger age group (median age of onset is 35 years)**, but it shows **no significant gender predilection**. Unlike other autoimmune conditions, it does not predominantly favor females in the 20-40 age bracket. Therefore, stating it is "common in females" specifically is inaccurate in the context of clinical epidemiology. **2. Analysis of other options:** * **Option B:** Characteristically, the wheals appear within minutes of sun exposure and **subside spontaneously within 1 to 24 hours** once the patient moves into the shade, leaving no residual scarring. * **Option C:** If a large surface area of the body is exposed, massive histamine release can lead to systemic symptoms, including **faintness, bronchospasm, or even anaphylaxis**. * **Option D:** The majority of cases are **idiopathic**. It is hypothesized to be a Type I hypersensitivity reaction to an endogenous "photo-allergen" created by light exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** Confirmed by **Phototesting** (determining the Minimal Urticarial Dose). * **Action Spectrum:** Most commonly triggered by **UVA** and visible light. * **Treatment:** First-line treatment is **H1 antihistamines**. For refractory cases, **PUVA (photodesensitization)** or Omalizumab may be used. * **Differential:** Differentiate from Polymorphous Light Eruption (PMLE), where lesions take hours/days to appear and days to resolve.

Q: What is the wavelength range of UVB rays?

290 - 320 nm. **Explanation:** The electromagnetic spectrum of ultraviolet (UV) radiation is divided into three bands based on wavelength and biological activity: UVA, UVB, and UVC. **1. Why Option A is Correct:** **UVB (290–320 nm)** is known as the "erythemal" or "sunburn" spectrum. It is the range responsible for delayed tanning, vitamin D synthesis, and the development of skin cancers (basal and squamous cell carcinomas). In clinical practice, **Narrowband UVB (311–313 nm)** is the gold standard for treating conditions like vitiligo and psoriasis due to its high efficacy and lower carcinogenic risk compared to broadband. **2. Analysis of Incorrect Options:** * **Options B & C (320–400 nm):** These fall within the **UVA** range. UVA is further divided into UVA2 (320–340 nm) and UVA1 (340–400 nm). UVA is responsible for immediate tanning and photoaging (dermatoheliosis) as it penetrates deeper into the dermis. * **Option D (390–420 nm):** This range transitions from the long-wave UVA spectrum into **Visible Light** (starting at approximately 400 nm). **3. High-Yield Clinical Pearls for NEET-PG:** * **UVC (200–290 nm):** Shortest wavelength, highest energy; mostly absorbed by the ozone layer. Used in germicidal lamps. * **Minimal Erythema Dose (MED):** The smallest dose of UV radiation that produces confluent erythema at 24 hours. UVB is 1000 times more erythrogenic than UVA. * **Photoaging:** Primarily caused by UVA (A for Aging). * **Phototherapy:** PUVA (Psoralen + UVA) uses the 320–400 nm range, while NB-UVB uses 311 nm.

Q: What is the range of light that causes maximum skin damage?

290-360 nm. **Explanation:** The spectrum of light responsible for the majority of skin damage encompasses **Ultraviolet B (UVB: 290–320 nm)** and **Ultraviolet A (UVA: 320–400 nm)**. The range **290–360 nm** is the most clinically significant because it includes the entirety of UVB—the most erythemogenic and carcinogenic wavelengths—and the "short-wave" UVA (UVA2) portion. * **UVB (290–320 nm):** Known as the "burning rays," these have high energy and are primarily responsible for DNA damage (pyrimidine dimers), sunburn (erythema), and skin cancers (BCC, SCC, and Melanoma). * **UVA (320–400 nm):** Known as "aging rays," these penetrate deeper into the dermis, causing photoaging and indirect DNA damage via reactive oxygen species (ROS). **Analysis of Incorrect Options:** * **A (360–400 nm):** This is UVA1 (long-wave UVA). While it contributes to photoaging and tanning, it is significantly less potent in causing acute biological damage or DNA mutations compared to the 290–360 nm range. * **C (240–290 nm):** This falls within the UVC range. While highly energetic and dangerous, UVC is almost entirely absorbed by the Earth’s ozone layer and does not reach the skin under normal conditions. * **D (760–800 nm):** This is part of the Near-Infrared/Visible light spectrum. These wavelengths primarily produce heat and do not possess enough energy to cause direct photochemical DNA damage. **High-Yield Clinical Pearls for NEET-PG:** * **Minimal Erythema Dose (MED):** The smallest dose of UV radiation that produces confluent erythema at 24 hours. It is used to calibrate phototherapy. * **Action Spectrum:** The specific wavelength of light that produces a particular biological response (e.g., 290–300 nm is the peak for erythema). * **Narrowband UVB (NBUVB):** 311–313 nm. This is the "Gold Standard" for treating Psoriasis and Vitiligo as it maximizes therapeutic effect while minimizing burning.

Q: A patient presents with skin bullae on sun exposure. What is the underlying defect?

Thymidine dimers. The clinical presentation of skin bullae (blistering) upon sun exposure, especially in the context of conditions like **Xeroderma Pigmentosum (XP)**, is rooted in the body's inability to repair ultraviolet (UV) light-induced damage. ### Explanation of the Correct Answer When skin is exposed to UV radiation (specifically UVB), it causes a photochemical reaction where two adjacent pyrimidine bases (most commonly **Thymidine**) on a DNA strand become covalently linked. This creates **Thymidine dimers** (cyclobutane pyrimidine dimers). In healthy individuals, these are repaired via **Nucleotide Excision Repair (NER)**. A defect in this repair mechanism leads to accumulated mutations, cell death (manifesting as bullae/blisters), and a high risk of skin malignancies. ### Why Other Options are Incorrect * **A. Sugar changes:** UV radiation primarily targets the nitrogenous bases of DNA, not the pentose sugar-phosphate backbone. * **B. DNA methylation:** This is an epigenetic mechanism involved in gene silencing. While it plays a role in cancer, it is not the primary acute lesion caused by UV light. * **D. Trinucleotide repeats:** These are associated with dynamic mutations seen in neurological disorders like Huntington’s disease or Fragile X syndrome, not photodermatoses. ### High-Yield Clinical Pearls for NEET-PG * **Xeroderma Pigmentosum:** The classic "prototype" disease for this defect. Inherited as Autosomal Recessive. * **Action Spectrum:** UVB (290–320 nm) is the most responsible for thymidine dimer formation. * **Key Enzyme:** The defect often lies in **UV-specific endonuclease**, which is required for the initial "incising" step of NER. * **Malignancy Risk:** Patients have a >1000-fold increased risk of Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), and Melanoma.

Q: What is the wavelength range of UVB radiation?

280-320 nm. **Explanation:** The electromagnetic spectrum of ultraviolet radiation is divided into three bands based on wavelength and biological activity: UVA, UVB, and UVC. **1. Why Option B is Correct:** **UVB (280–320 nm)** is known as "mid-range" UV or "sunburn radiation." It is biologically very active but is mostly absorbed by the stratum corneum and the epidermis. In dermatology, it is used for phototherapy (specifically Narrowband UVB at 311–313 nm) to treat conditions like psoriasis and vitiligo. **2. Analysis of Incorrect Options:** * **Option A (200–280 nm):** This represents **UVC** (Short-wave UV). It is germicidal but is almost entirely filtered out by the Earth’s ozone layer. * **Option C (320–400 nm):** This represents **UVA** (Long-wave UV). It penetrates deeper into the dermis and is responsible for immediate pigment darkening and photoaging. It is further divided into UVA1 (340–400 nm) and UVA2 (320–340 nm). * **Option D (400–700 nm):** This represents the **Visible Light** spectrum, which is perceived by the human eye. **Clinical Pearls for NEET-PG:** * **Narrowband UVB (NB-UVB):** The peak therapeutic wavelength is **311 nm**. It is the treatment of choice for stable vitiligo and plaque psoriasis due to its high efficacy and lower carcinogenic potential compared to PUVA. * **Vitamin D Synthesis:** UVB is the specific range responsible for the conversion of 7-dehydrocholesterol to Vitamin D3 in the skin. * **Minimal Erythema Dose (MED):** This is the smallest dose of UV radiation that produces confluent erythema at 24 hours. MED is significantly lower for UVB than for UVA.

Phototherapy and Photobiology Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is NOT a complication of PUVA therapy?

A. Premature aging of the skin
B. Cataracts
C. Skin cancers
D. Exfoliative dermatitis (Correct Answer)

Explanation: **Explanation:** PUVA (Psoralen + Ultraviolet A) therapy involves the administration of a photosensitizer (8-methoxypsoralen) followed by exposure to UVA radiation. While it is an effective treatment for conditions like psoriasis and vitiligo, it carries specific long-term and short-term risks. **Why Exfoliative Dermatitis is the correct answer:** Exfoliative dermatitis (Erythroderma) is **not** a direct complication of PUVA. In fact, PUVA is often used as a *treatment* modality for certain types of exfoliative dermatitis, such as those caused by Mycosis Fungoides or Psoriasis. While PUVA can cause a "PUVA itch" or a phototoxic burn (erythema), it does not typically trigger generalized exfoliation. **Analysis of Incorrect Options:** * **Premature aging of the skin (Dermatoheliosis):** Chronic UVA exposure leads to the degradation of collagen and elastin fibers, resulting in wrinkles, lentigines, and telangiectasia. * **Cataracts:** Psoralens distribute to the lens of the eye. If the eyes are not protected with UVA-blocking sunglasses for 24 hours post-ingestion, UVA exposure can lead to lens opacification. * **Skin cancers:** PUVA is mutagenic. Long-term therapy significantly increases the risk of Non-Melanoma Skin Cancers (NMSC), particularly **Squamous Cell Carcinoma (SCC)**. **High-Yield Clinical Pearls for NEET-PG:** * **Most common acute side effect:** Erythema (phototoxicity) and pruritus. * **Most common long-term risk:** Squamous Cell Carcinoma (SCC) is more common than Basal Cell Carcinoma (BCC) in PUVA patients (reversing the usual ratio). * **PUVA Lentigines:** Distinctive, irregular pigmented macules that appear after chronic therapy. * **Contraindications:** Pregnancy, lactation, history of skin cancer (Xeroderma Pigmentosum), and severe hepatic/renal failure.

Question 2: A 12-year-old boy, after spending his holiday on a beach, develops pruritic hemorrhagic vesicles on his cheeks, ears, nose, and hands 12 hours after sun exposure. A week later, the lesions crusted and healed with permanent scars. What is the most probable diagnosis?

A. Polymorphic light eruption
B. Hydroa vacciniforme (Correct Answer)
C. Actinic prurigo
D. Persistent light reaction

Explanation: **Explanation:** The clinical presentation of a young boy with **hemorrhagic vesicles** on sun-exposed areas (cheeks, ears, nose, hands) that heal with **permanent scarring** (varioliform scars) is pathognomonic for **Hydroa vacciniforme (HV)**. **Why Hydroa vacciniforme is correct:** HV is a rare, chronic photodermatosis primarily affecting children. It is triggered by UVA radiation. The hallmark is the progression from erythema to vesicles/bullae, which become umbilicated and hemorrhagic, eventually forming necrotic crusts. The defining feature for NEET-PG is the healing process, which results in **depressed, "vacciniform" (smallpox-like) scars**. It is often associated with **Epstein-Barr Virus (EBV)** infection. **Why other options are incorrect:** * **Polymorphic Light Eruption (PMLE):** The most common photodermatosis. While it causes pruritic papules or vesicles, it **never heals with scarring**. * **Actinic Prurigo:** A variant of PMLE common in Native Americans. It presents with intensely pruritic, excoriated papules and nodules, often involving the lips (cheilitis) and conjunctiva, but does not typically present with hemorrhagic vesicles and varioliform scarring. * **Persistent Light Reaction:** Now classified under Chronic Actinic Dermatitis. It is an eczematous reaction seen in elderly males, where skin remains sensitive to light even without allergen exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Action Spectrum:** UVA is the primary trigger for HV. * **Association:** Severe, systemic cases of HV are linked to **EBV-associated T-cell lymphoproliferative disorders**. * **Differential Diagnosis:** Must be distinguished from Erythropoietic Protoporphyria (EPP), which presents with immediate burning pain and waxy scarring, but lacks the hemorrhagic bullae of HV. * **Management:** Strict photoprotection; severe cases may require antimalarials or immunosuppressants.

Question 3: Psoralen plus ultraviolet A (PUVA) therapy is useful in which of the following conditions?

A. Vitiligo
B. Mycosis fungoides
C. Psoriasis
D. All of the above (Correct Answer)

Explanation: **Explanation:** **PUVA (Psoralen + UVA)** therapy involves the administration of a photosensitizing agent (8-Methoxypsoralen) followed by exposure to long-wave ultraviolet A light (320–400 nm). The mechanism involves the formation of DNA photo-adducts, which inhibit DNA synthesis and induce apoptosis of hyperproliferating cells and T-lymphocytes. **Why "All of the Above" is Correct:** * **Psoriasis:** PUVA is a classic treatment for moderate-to-severe plaque psoriasis. It reduces the rapid turnover of keratinocytes and suppresses the local cutaneous immune response. * **Vitiligo:** Psoralens stimulate the migration and proliferation of melanocytes from the hair follicle reservoir to the depigmented skin, promoting repigmentation. * **Mycosis Fungoides (MF):** As a cutaneous T-cell lymphoma, MF is highly sensitive to the phototoxic effects of PUVA, which induces apoptosis in malignant T-cells infiltrating the epidermis. **Clinical Pearls for NEET-PG:** 1. **Mechanism:** Psoralens intercalate into DNA; UVA then causes **Type I (oxygen-independent)** reactions forming monoadducts/cross-links and **Type II (oxygen-dependent)** reactions forming free radicals. 2. **Dosage:** Oral psoralen is usually given **0.6 mg/kg**, 2 hours before UVA exposure. 3. **Side Effects:** Acute side effects include nausea and erythema. Long-term risks include **PUVA lentigines** and an increased risk of **Squamous Cell Carcinoma (SCC)**. 4. **Contraindication:** PUVA is contraindicated in patients with Xeroderma Pigmentosum, Lupus Erythematosus, and pregnancy. 5. **Current Trend:** Narrowband UVB (311 nm) has largely replaced PUVA for psoriasis and vitiligo due to a better safety profile, but PUVA remains superior for thick plaques and MF.

Question 4: Psoralen is used in the treatment of:

A. Pemphigus
B. Vitiligo (Correct Answer)
C. Pityriasis alba
D. Ichthyosis

Explanation: **Explanation:** **Psoralen** is a photosensitizing agent used in **PUVA (Psoralen + Ultraviolet A)** therapy. It belongs to the furocoumarin family and works by intercalating into DNA. Upon exposure to UVA light, it forms DNA cross-links, which inhibits keratinocyte proliferation and induces melanocyte stimulation. **Why Vitiligo is correct:** In Vitiligo, PUVA therapy is a classic treatment modality. It works by: 1. **Immunomodulation:** Suppressing the T-cell mediated destruction of melanocytes. 2. **Melanocyte Stimulation:** Promoting the migration of melanocytes from the hair follicle reservoir to the depigmented skin, leading to repigmentation. **Why other options are incorrect:** * **Pemphigus:** This is an autoimmune bullous disorder treated primarily with systemic corticosteroids and immunosuppressants (e.g., Rituximab, Azathioprine), not phototherapy. * **Pityriasis alba:** This is a mild form of dermatitis common in children, usually associated with atopy. It is treated with emollients and low-potency topical steroids; psoralens are not indicated. * **Ichthyosis:** This is a genetic disorder of keratinization characterized by fish-like scales. Treatment involves keratolytics (e.g., urea, lactic acid) and systemic retinoids. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Psoralens (e.g., 8-Methoxypsoralen) bind to pyrimidine bases (thymine) in DNA. * **Common Indications for PUVA:** Psoriasis (most common), Vitiligo, Mycosis Fungoides (CTCL), and Alopecia Areata. * **Side Effects:** Acute side effects include nausea and polymorphic light eruption. Long-term risks include **PUVA lentigines** and an increased risk of **Squamous Cell Carcinoma (SCC)**. * **Contraindication:** PUVA is contraindicated in patients with Xeroderma Pigmentosum, SLE, or a history of skin cancer.

Question 5: All of the following are true about solar urticaria EXCEPT:

A. Common in females between the age group of 20-40 years. (Correct Answer)
B. Lesions subside spontaneously on avoiding exposure within 24 hours.
C. Some cases may develop severe urticaria or bronchospasm.
D. Almost all cases are idiopathic.

Explanation: **Explanation:** Solar urticaria is a rare, IgE-mediated physical urticaria triggered by exposure to ultraviolet (UV) or visible light. **1. Why Option A is the correct answer (The Exception):** While solar urticaria can occur at any age, the peak incidence is actually in the **younger age group (median age of onset is 35 years)**, but it shows **no significant gender predilection**. Unlike other autoimmune conditions, it does not predominantly favor females in the 20-40 age bracket. Therefore, stating it is "common in females" specifically is inaccurate in the context of clinical epidemiology. **2. Analysis of other options:** * **Option B:** Characteristically, the wheals appear within minutes of sun exposure and **subside spontaneously within 1 to 24 hours** once the patient moves into the shade, leaving no residual scarring. * **Option C:** If a large surface area of the body is exposed, massive histamine release can lead to systemic symptoms, including **faintness, bronchospasm, or even anaphylaxis**. * **Option D:** The majority of cases are **idiopathic**. It is hypothesized to be a Type I hypersensitivity reaction to an endogenous "photo-allergen" created by light exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** Confirmed by **Phototesting** (determining the Minimal Urticarial Dose). * **Action Spectrum:** Most commonly triggered by **UVA** and visible light. * **Treatment:** First-line treatment is **H1 antihistamines**. For refractory cases, **PUVA (photodesensitization)** or Omalizumab may be used. * **Differential:** Differentiate from Polymorphous Light Eruption (PMLE), where lesions take hours/days to appear and days to resolve.

Question 6: What is the wavelength range of UVB rays?

A. 290 - 320 nm (Correct Answer)
B. 320 - 360 nm
C. 360 - 390 nm
D. 390 - 420 nm

Explanation: **Explanation:** The electromagnetic spectrum of ultraviolet (UV) radiation is divided into three bands based on wavelength and biological activity: UVA, UVB, and UVC. **1. Why Option A is Correct:** **UVB (290–320 nm)** is known as the "erythemal" or "sunburn" spectrum. It is the range responsible for delayed tanning, vitamin D synthesis, and the development of skin cancers (basal and squamous cell carcinomas). In clinical practice, **Narrowband UVB (311–313 nm)** is the gold standard for treating conditions like vitiligo and psoriasis due to its high efficacy and lower carcinogenic risk compared to broadband. **2. Analysis of Incorrect Options:** * **Options B & C (320–400 nm):** These fall within the **UVA** range. UVA is further divided into UVA2 (320–340 nm) and UVA1 (340–400 nm). UVA is responsible for immediate tanning and photoaging (dermatoheliosis) as it penetrates deeper into the dermis. * **Option D (390–420 nm):** This range transitions from the long-wave UVA spectrum into **Visible Light** (starting at approximately 400 nm). **3. High-Yield Clinical Pearls for NEET-PG:** * **UVC (200–290 nm):** Shortest wavelength, highest energy; mostly absorbed by the ozone layer. Used in germicidal lamps. * **Minimal Erythema Dose (MED):** The smallest dose of UV radiation that produces confluent erythema at 24 hours. UVB is 1000 times more erythrogenic than UVA. * **Photoaging:** Primarily caused by UVA (A for Aging). * **Phototherapy:** PUVA (Psoralen + UVA) uses the 320–400 nm range, while NB-UVB uses 311 nm.

Question 7: What is the range of light that causes maximum skin damage?

A. 360-400 nm
B. 290-360 nm (Correct Answer)
C. 240-290 nm
D. 760-800 nm

Explanation: **Explanation:** The spectrum of light responsible for the majority of skin damage encompasses **Ultraviolet B (UVB: 290–320 nm)** and **Ultraviolet A (UVA: 320–400 nm)**. The range **290–360 nm** is the most clinically significant because it includes the entirety of UVB—the most erythemogenic and carcinogenic wavelengths—and the "short-wave" UVA (UVA2) portion. * **UVB (290–320 nm):** Known as the "burning rays," these have high energy and are primarily responsible for DNA damage (pyrimidine dimers), sunburn (erythema), and skin cancers (BCC, SCC, and Melanoma). * **UVA (320–400 nm):** Known as "aging rays," these penetrate deeper into the dermis, causing photoaging and indirect DNA damage via reactive oxygen species (ROS). **Analysis of Incorrect Options:** * **A (360–400 nm):** This is UVA1 (long-wave UVA). While it contributes to photoaging and tanning, it is significantly less potent in causing acute biological damage or DNA mutations compared to the 290–360 nm range. * **C (240–290 nm):** This falls within the UVC range. While highly energetic and dangerous, UVC is almost entirely absorbed by the Earth’s ozone layer and does not reach the skin under normal conditions. * **D (760–800 nm):** This is part of the Near-Infrared/Visible light spectrum. These wavelengths primarily produce heat and do not possess enough energy to cause direct photochemical DNA damage. **High-Yield Clinical Pearls for NEET-PG:** * **Minimal Erythema Dose (MED):** The smallest dose of UV radiation that produces confluent erythema at 24 hours. It is used to calibrate phototherapy. * **Action Spectrum:** The specific wavelength of light that produces a particular biological response (e.g., 290–300 nm is the peak for erythema). * **Narrowband UVB (NBUVB):** 311–313 nm. This is the "Gold Standard" for treating Psoriasis and Vitiligo as it maximizes therapeutic effect while minimizing burning.

Question 8: Circulating lymphocytes are most sensitive to which type of ultraviolet radiation?

A. UV-A
B. UV-B
C. UV-C (Correct Answer)
D. 760-800 nm wavelength light

Explanation: **Explanation:** The correct answer is **UV-C (200–280 nm)**. **1. Why UV-C is correct:** The sensitivity of cells to ultraviolet radiation is primarily determined by the absorption spectrum of DNA and nuclear proteins. DNA has a peak absorption at approximately **260 nm**, which falls squarely within the UV-C range. Circulating lymphocytes are highly susceptible to DNA damage and subsequent apoptosis when exposed to these short wavelengths. While UV-C from sunlight is filtered out by the Earth’s ozone layer and does not reach the skin surface, it is used clinically in **Extracorporeal Photopheresis (ECP)**. In ECP, lymphocytes are treated outside the body; UV-C is the most potent inducer of lymphocyte apoptosis among the UV spectrum. **2. Why other options are incorrect:** * **UV-A (320–400 nm):** These longer wavelengths penetrate deeper into the dermis but have low energy. They primarily cause oxidative stress rather than direct DNA breaks. While used in PUVA therapy, UV-A is significantly less "cytotoxic" to lymphocytes than UV-C. * **UV-B (280–320 nm):** UV-B causes direct DNA damage (pyrimidine dimers) and is responsible for sunburn. While it can affect lymphocytes in the superficial dermis, its energy levels and DNA-absorption efficiency are lower than UV-C. * **760–800 nm:** This range corresponds to **Infrared/Visible light**. These wavelengths do not possess enough energy to cause the photochemical reactions required to damage lymphocyte DNA. **High-Yield Clinical Pearls for NEET-PG:** * **Action Spectrum:** The specific wavelength that produces a biological response (e.g., 260 nm for DNA damage). * **Extracorporeal Photopheresis (ECP):** Used for Cutaneous T-cell Lymphoma (CTCL/Sezary Syndrome) and Graft-vs-Host Disease (GVHD). * **Minimal Erythema Dose (MED):** Most commonly associated with **UV-B** (the "burning" rays). * **Grotthus-Draper Law:** Light must be absorbed by a molecule (chromophore) to exert a biological effect.

Question 9: A patient presents with skin bullae on sun exposure. What is the underlying defect?

A. Sugar changes
B. DNA methylation
C. Thymidine dimers (Correct Answer)
D. Trinucleotide repeats

Explanation: The clinical presentation of skin bullae (blistering) upon sun exposure, especially in the context of conditions like **Xeroderma Pigmentosum (XP)**, is rooted in the body's inability to repair ultraviolet (UV) light-induced damage. ### Explanation of the Correct Answer When skin is exposed to UV radiation (specifically UVB), it causes a photochemical reaction where two adjacent pyrimidine bases (most commonly **Thymidine**) on a DNA strand become covalently linked. This creates **Thymidine dimers** (cyclobutane pyrimidine dimers). In healthy individuals, these are repaired via **Nucleotide Excision Repair (NER)**. A defect in this repair mechanism leads to accumulated mutations, cell death (manifesting as bullae/blisters), and a high risk of skin malignancies. ### Why Other Options are Incorrect * **A. Sugar changes:** UV radiation primarily targets the nitrogenous bases of DNA, not the pentose sugar-phosphate backbone. * **B. DNA methylation:** This is an epigenetic mechanism involved in gene silencing. While it plays a role in cancer, it is not the primary acute lesion caused by UV light. * **D. Trinucleotide repeats:** These are associated with dynamic mutations seen in neurological disorders like Huntington’s disease or Fragile X syndrome, not photodermatoses. ### High-Yield Clinical Pearls for NEET-PG * **Xeroderma Pigmentosum:** The classic "prototype" disease for this defect. Inherited as Autosomal Recessive. * **Action Spectrum:** UVB (290–320 nm) is the most responsible for thymidine dimer formation. * **Key Enzyme:** The defect often lies in **UV-specific endonuclease**, which is required for the initial "incising" step of NER. * **Malignancy Risk:** Patients have a >1000-fold increased risk of Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), and Melanoma.

Question 10: What is the wavelength range of UVB radiation?

A. 250-280 nm
B. 280-320 nm (Correct Answer)
C. 320-400 nm
D. 400-700 nm

Explanation: **Explanation:** The electromagnetic spectrum of ultraviolet radiation is divided into three bands based on wavelength and biological activity: UVA, UVB, and UVC. **1. Why Option B is Correct:** **UVB (280–320 nm)** is known as "mid-range" UV or "sunburn radiation." It is biologically very active but is mostly absorbed by the stratum corneum and the epidermis. In dermatology, it is used for phototherapy (specifically Narrowband UVB at 311–313 nm) to treat conditions like psoriasis and vitiligo. **2. Analysis of Incorrect Options:** * **Option A (200–280 nm):** This represents **UVC** (Short-wave UV). It is germicidal but is almost entirely filtered out by the Earth’s ozone layer. * **Option C (320–400 nm):** This represents **UVA** (Long-wave UV). It penetrates deeper into the dermis and is responsible for immediate pigment darkening and photoaging. It is further divided into UVA1 (340–400 nm) and UVA2 (320–340 nm). * **Option D (400–700 nm):** This represents the **Visible Light** spectrum, which is perceived by the human eye. **Clinical Pearls for NEET-PG:** * **Narrowband UVB (NB-UVB):** The peak therapeutic wavelength is **311 nm**. It is the treatment of choice for stable vitiligo and plaque psoriasis due to its high efficacy and lower carcinogenic potential compared to PUVA. * **Vitamin D Synthesis:** UVB is the specific range responsible for the conversion of 7-dehydrocholesterol to Vitamin D3 in the skin. * **Minimal Erythema Dose (MED):** This is the smallest dose of UV radiation that produces confluent erythema at 24 hours. MED is significantly lower for UVB than for UVA.

Question 11: A 40-year-old farmer with a history of recurrent attacks of porphyria complains of itching when exposed to the sun and a maculopapular rash on sun-exposed areas. His symptoms are exaggerated in the summer. What is the diagnosis?

A. Seborrheic dermatitis
B. Contact dermatitis
C. Psoriasis
D. Porphyria cutanea tarda (Correct Answer)

Explanation: **Explanation** **Porphyria Cutanea Tarda (PCT)** is the most common type of porphyria. It results from a deficiency of the enzyme **uroporphyrinogen decarboxylase (UROD)**. The clinical presentation in this case—a farmer (chronic sun exposure) with a history of porphyria and symptoms worsening in the summer—is classic for PCT. The underlying pathophysiology involves the accumulation of porphyrins in the skin. When exposed to long-wave ultraviolet light (UVA), these porphyrins generate reactive oxygen species, leading to **photosensitivity**, skin fragility, and the characteristic maculopapular rash, vesicles, or bullae on sun-exposed areas (dorsum of hands, face). **Why other options are incorrect:** * **Seborrheic Dermatitis:** Typically affects "seborrheic" areas rich in oil glands (scalp, eyebrows, nasolabial folds) and presents with greasy scales, not photosensitivity. * **Contact Dermatitis:** This is a Type IV hypersensitivity reaction to an external allergen (e.g., nickel, cement). While it can occur on exposed skin, it is not triggered by porphyria or specifically seasonal/sun-dependent unless it is "photoallergic," which doesn't fit the patient's history. * **Psoriasis:** Characterized by well-demarcated erythematous plaques with silvery scales. Interestingly, sunlight usually *improves* psoriasis rather than exacerbating it. **High-Yield Clinical Pearls for NEET-PG:** * **Key Association:** PCT is strongly associated with **Hepatitis C virus (HCV)** infection, alcohol consumption, and iron overload. * **Diagnosis:** Look for "tea-colored" or "port-wine" urine. Wood’s lamp examination of urine shows **coral-red fluorescence**. * **Treatment:** Small-volume phlebotomy (to reduce iron) or low-dose hydroxychloroquine. * **Hallmark:** Hypertrichosis (increased hair growth) on the temples and malar area is a common associated finding in PCT.

Question 12: All of the following are true about solar urticaria, EXCEPT:

A. Common in females between age group above 40 years (Correct Answer)
B. Lesions subside spontaneously on avoiding exposure within 24 hours
C. Some cases may develop severe urticaria/bronchospasm
D. Almost all cases are idiopathic

Explanation: **Solar Urticaria** is a rare form of physical urticaria characterized by the rapid onset of wheals and erythema within minutes of exposure to ultraviolet (UV) or visible light. ### **Explanation of Options:** * **Option A (Correct Answer):** This statement is incorrect because solar urticaria typically affects **young adults**, with a peak onset between **20 and 40 years** of age. While it does show a slight female preponderance, it is not primarily a disease of the elderly or those above 40. * **Option B:** This is a classic feature. The wheals appear within 5–10 minutes of sun exposure and characteristically **resolve within 1–24 hours** (usually within 1–2 hours) once the patient moves into the shade. * **Option C:** In cases of extensive body surface area exposure, patients can experience systemic symptoms due to massive histamine release, including **bronchospasm, hypotension, and syncope** (anaphylactoid reaction). * **Option D:** Most cases are **idiopathic**. It is hypothesized to be a Type I hypersensitivity reaction where an endogenous precursor (chromophore) is converted into an allergen by specific wavelengths of light. ### **High-Yield Clinical Pearls for NEET-PG:** 1. **Action Spectrum:** Most commonly triggered by **UVA** (320–400 nm) and **Visible Light**, though UVB can also be a trigger. 2. **Diagnosis:** Confirmed by **Phototesting**, where the skin is exposed to specific wavelengths to determine the Minimal Urticarial Dose (MUD). 3. **The "Fixed" Variant:** Unlike most urticarias, some patients have a "fixed" solar urticaria where lesions only appear on specific skin sites. 4. **Management:** First-line treatment involves **H1-antihistamines**. For refractory cases, **Photodesensitization** (hardening) or Omalizumab may be used. 5. **Differential Diagnosis:** Must be distinguished from Polymorphous Light Eruption (PMLE), which takes hours to days to appear and days to resolve.

Question 13: What is the mechanism of action of psoralen?

A. Binding to DNA (Correct Answer)
B. Inhibiting protein synthesis
C. Inhibiting angiogenesis
D. Inhibiting keratinization

Explanation: **Explanation:** The correct answer is **A. Binding to DNA**. **Mechanism of Action:** Psoralens (e.g., 8-Methoxypsoralen) are photosensitizing agents used in **PUVA (Psoralen + UVA)** therapy. The mechanism occurs in two distinct phases: 1. **Type I Reaction (Oxygen-independent):** Psoralens intercalate between the base pairs of the DNA helix. Upon exposure to UVA radiation (320–400 nm), they form **monoadducts** and **bifunctional adducts (interstrand cross-links)** with pyrimidine bases (primarily thymine). This inhibits DNA synthesis and keratinocyte proliferation, which is the primary therapeutic effect in psoriasis. 2. **Type II Reaction (Oxygen-dependent):** UVA excites the psoralen molecule, transferring energy to molecular oxygen to create reactive oxygen species (ROS), leading to cell membrane damage and melanocyte stimulation. **Why other options are incorrect:** * **B & D:** While PUVA ultimately leads to decreased protein synthesis and altered keratinization as a *downstream result* of DNA damage and cell cycle arrest, these are not the primary molecular mechanisms. * **C:** Inhibiting angiogenesis is a feature of certain systemic retinoids or biologicals, but it is not the defining mechanism of psoralens. **High-Yield Clinical Pearls for NEET-PG:** * **Action Spectrum:** UVA (320–400 nm) is required to activate psoralen. * **Indications:** Psoriasis, Vitiligo (stimulates melanocytes), and Mycosis Fungoides (CTCL). * **Side Effects:** Acute (erythema, pruritus) and Chronic (Photoaging, **Squamous Cell Carcinoma**). * **Ocular Safety:** Patients must wear UVA-blocking goggles for 24 hours after ingestion to prevent **cataracts**, as psoralen distributes to the lens.

Question 14: A 45-year-old farmer presents with itchy erythematous papular lesions on the face, neck, 'V' area of the chest, and dorsum of hands and forearms, present for 3 years. The lesions are more severe in summers and improve in winters. What is the most appropriate diagnostic test for this condition?

A. Skin biopsy (Correct Answer)
B. Estimation of IgE levels in blood
C. Patch test
D. Intradermal prick test

Explanation: ### Explanation **Diagnosis: Chronic Actinic Dermatitis (CAD)** The clinical presentation—a middle-aged farmer with itchy, erythematous lesions in a **photo-distributed pattern** (face, V-area of chest, dorsum of hands) that exacerbates in summer—is classic for **Chronic Actinic Dermatitis (CAD)**. CAD is an immunologically mediated photodermatosis that often begins as an eczematous reaction to light. **1. Why Skin Biopsy is the Correct Answer:** While the diagnosis of CAD is primarily clinical, a **skin biopsy** is the most appropriate diagnostic step to confirm the diagnosis and, more importantly, to **rule out mimics** like Mycosis Fungoides (Cutaneous T-cell Lymphoma). Histopathology in CAD typically shows an eczematous pattern (spongiosis) or, in severe cases (Actinic Reticuloid), a dense dermal infiltrate that can resemble lymphoma. **2. Why Other Options are Incorrect:** * **Patch Test (Option C):** While many CAD patients have associated contact allergies (e.g., to Compositae plants or fragrances), a patch test identifies contact allergens, not the primary photosensitivity. A *Photo-patch test* would be more relevant, but biopsy remains the gold standard for definitive characterization. * **Estimation of IgE (Option B):** Elevated IgE is a marker for Atopic Dermatitis, not photodermatoses. * **Intradermal Prick Test (Option D):** This is used to diagnose Type I hypersensitivity (e.g., allergic rhinitis or asthma) and has no role in diagnosing CAD. **Clinical Pearls for NEET-PG:** * **CAD Spectrum:** Includes Photosensitive Eczema and Actinic Reticuloid. * **Demographics:** Typically affects elderly males (often outdoor workers like farmers). * **Photo-testing:** Patients show a **reduced Minimal Erythema Dose (MED)** to UVA, UVB, and sometimes visible light. * **Management:** Strict photoprotection, topical steroids, and in refractory cases, systemic immunosuppressants (Azathioprine).

Question 15: What is the typical wavelength range of a Wood's lamp?

A. 360-385 nm (Correct Answer)
B. 280-320 nm
C. 400-450 nm
D. 450-500 nm

Explanation: ### Explanation **1. Why Option A is Correct:** A Wood’s lamp (also known as a black light) is a diagnostic tool that emits long-wave Ultraviolet A (UVA) radiation. The device uses a high-pressure mercury arc lamp with a specialized filter called a **Wood’s filter** (composed of barium silicate with 9% nickel oxide). This filter is opaque to all light except for a specific band in the UVA spectrum, typically peaking at **365 nm**, with a functional range of **360–385 nm**. When this light hits certain substances (fluorophores) on the skin or hair, they absorb the energy and re-emit it as visible light (fluorescence). **2. Why Other Options are Incorrect:** * **Option B (280–320 nm):** This represents the **UVB spectrum**. This range is used in phototherapy (e.g., Narrowband UVB at 311 nm) for psoriasis and vitiligo but is not the wavelength of a Wood’s lamp. * **Option C (400–450 nm):** This is the **Visible Blue Light** range. While used in treating neonatal jaundice or PDT, it is beyond the UV spectrum of a Wood’s lamp. * **Option D (450–500 nm):** This is the **Cyan/Green visible light** range, which does not possess the properties required for diagnostic fluorescence in dermatology. **3. Clinical Pearls for NEET-PG:** * **Tinea Capitis:** *Microsporum* species show **Brilliant Green** fluorescence (due to Pteridine). *Trichophyton schoenleinii* shows **Dull Blue**. * **Erythrasma:** Caused by *Corynebacterium minutissimum*; shows **Coral Red** fluorescence (due to Coproporphyrin III). * **Porphyria Cutanea Tarda:** Urine shows **Pink-Orange** fluorescence. * **Pseudomonas:** Shows **Yellow-Green** fluorescence (due to Pyoverdin). * **Vitiligo:** Shows **Milky White** fluorescence (helps distinguish from pityriasis alba, which does not fluoresce). * **Note:** Always perform the examination in a **dark room** to visualize the weak fluorescence.

Question 16: All are true regarding Polymorphous light eruption (PMLE), EXCEPT?

A. Rash caused by sun exposure
B. Rash triggered by exposure to artificial ultraviolet (UV) light
C. Healing without scarring
D. Face is always affected (Correct Answer)

Explanation: **Explanation:** Polymorphous Light Eruption (PMLE) is the most common idiopathic primary photodermatosis. It is a delayed-type hypersensitivity reaction to an endogenous antigen induced by UV radiation. **Why Option D is the Correct Answer (The Exception):** The **face is frequently spared** in PMLE. This is due to the phenomenon of **"hardening"** (photo-tolerance). Areas chronically exposed to the sun, like the face and back of the hands, develop a tolerance to UV light. PMLE characteristically affects "intermittently exposed" areas, such as the V-area of the neck, forearms, and upper arms, especially during the first strong sun exposure of spring or summer. **Analysis of Other Options:** * **Option A & B:** PMLE is triggered by sunlight, specifically **UVA** (most common) and sometimes UVB or even artificial UV sources (tanning beds). The rash typically appears hours to days after exposure. * **Option C:** Despite the "polymorphic" nature of the lesions (papules, vesicles, or plaques), they are superficial and inflammatory. They resolve spontaneously within 7–10 days if further sun exposure is avoided, **healing without any permanent scarring.** **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Most common presentation is the **papular variant**. * **Seasonality:** Typically occurs in spring/early summer; improves as summer progresses due to the "hardening" effect. * **Gender Predilection:** More common in females (2:1 ratio). * **Management:** Photoprotection (broad-spectrum sunscreens) is first-line. Severe cases may require topical steroids or "prophylactic desensitization" using narrow-band UVB (NB-UVB) or PUVA.

Question 17: On a 4 Gy dose of radiation to the scalp, when does alopecia typically develop?

A. 3-4 weeks (Correct Answer)
B. 6-8 weeks
C. 10-12 weeks
D. 14-16 weeks

Explanation: **Explanation:** The correct answer is **A. 3-4 weeks.** **Medical Concept:** Radiation-induced alopecia occurs due to the high mitotic activity of hair follicle matrix cells, which makes them exquisitely sensitive to ionizing radiation. A dose of **4 Gy (400 rads)** is sufficient to cause **temporary effluvium**. Following exposure, the hair follicles enter a dystrophic state, leading to hair shedding. This process typically manifests clinically after a latent period of **3 to 4 weeks**, as it takes time for the damaged hair shaft to separate and be extruded from the follicle. **Analysis of Options:** * **A (3-4 weeks):** Correct. This matches the physiological timeline of hair matrix arrest and subsequent shedding following a single sub-epilating or epilating dose of radiation. * **B, C, and D:** These timelines are too late. While permanent alopecia (occurring at doses >7 Gy) results in long-term hair loss, the initial shedding still begins within the first month. Waiting 6 to 16 weeks would be more characteristic of *telogen effluvium* (triggered by systemic stress) rather than acute radiation injury. **High-Yield Clinical Pearls for NEET-PG:** * **Threshold Doses:** * **3-5 Gy:** Causes temporary alopecia (regrowth begins in 2-4 months). * **>7-10 Gy:** Can cause permanent alopecia due to irreversible damage to the stem cells in the hair bulge. * **Radiotherapy & Hair:** The most common type of hair loss post-radiation is **Anagen Effluvium**, where the hair shaft narrows (Pohl-Pinkus marks) and breaks. * **Historical Context:** In the past, the "Adamson-Kienbock point technique" used X-rays to induce epilation for treating Tinea Capitis, aiming for this exact 3-week window.

Question 18: What is the wavelength range of UVB rays?

A. 290 - 320 nm (Correct Answer)
B. 320 - 360 nm
C. 360 - 390 nm
D. 390 - 420 nm

Explanation: **Explanation:** The electromagnetic spectrum of ultraviolet radiation is divided into three bands based on wavelength and biological activity: UVA, UVB, and UVC. **Correct Answer: A (290 – 320 nm)** UVB radiation, often called the "erythemal" or "burning" spectrum, ranges from **290 to 320 nm**. It is primarily responsible for delayed tanning, sunburn (erythema), and vitamin D synthesis. In clinical dermatology, Narrow-band UVB (NB-UVB), which uses a specific peak at **311 nm**, is the gold standard for treating vitiligo and psoriasis due to its high efficacy and lower carcinogenic potential compared to Broad-band UVB. **Analysis of Incorrect Options:** * **B & C (320 – 400 nm):** These ranges fall under **UVA**. UVA is further divided into UVA2 (320–340 nm) and UVA1 (340–400 nm). UVA is responsible for immediate pigment darkening and photoaging. * **D (390 – 420 nm):** This range transitions from the end of the ultraviolet spectrum into **Visible Light** (which begins at approximately 400 nm). **High-Yield Clinical Pearls for NEET-PG:** 1. **UVC (200–290 nm):** It is the most germicidal but does not reach the earth's surface as it is absorbed by the ozone layer. 2. **Minimal Erythema Dose (MED):** This is the smallest dose of UVB required to produce confluent erythema at 24 hours. It is used to determine the starting dose for phototherapy. 3. **DNA Damage:** UVB is primarily absorbed by DNA, leading to the formation of **cyclobutane pyrimidine dimers**, which can lead to skin cancers (BCC, SCC). 4. **Window Glass:** UVB is blocked by window glass, whereas UVA can penetrate it.

Question 19: Which of the following skin conditions is treated with PUVA therapy?

A. Psoriasis (Correct Answer)
B. Tinea versicolor
C. Lichen planus
D. Porphyria cutanea tarda

Explanation: **Explanation** **PUVA (Psoralen + Ultraviolet A)** therapy is a form of photochemotherapy that combines the administration of a photosensitizing agent (Psoralen) with exposure to UVA radiation (320–400 nm). **1. Why Psoriasis is correct:** Psoriasis is a chronic inflammatory skin disorder characterized by keratinocyte hyperproliferation and T-cell mediated inflammation. PUVA works by intercalating Psoralen into the DNA of rapidly dividing cells. Upon exposure to UVA, it forms DNA cross-links (cyclobutane dimers), which inhibit DNA synthesis and suppress cellular proliferation. Additionally, PUVA induces apoptosis of T-lymphocytes, leading to local immunosuppression and clearing of psoriatic plaques. **2. Why other options are incorrect:** * **Tinea versicolor:** This is a superficial fungal infection caused by *Malassezia furfur*. It is treated with topical or systemic antifungals (e.g., Ketoconazole), not phototherapy. * **Lichen planus:** While Narrowband UVB (NBUVB) can be used for generalized lichen planus, PUVA is not the primary treatment. Furthermore, in the context of standard NEET-PG questions, Psoriasis remains the "gold standard" indication for PUVA. * **Porphyria cutanea tarda (PCT):** This is a metabolic disorder of heme synthesis. UV light actually *exacerbates* porphyrias (photosensitivity). Treatment involves phlebotomy or low-dose hydroxychloroquine. **Clinical Pearls for NEET-PG:** * **Wavelength:** UVA (320–400 nm); NBUVB (311–312 nm). NBUVB is now preferred over PUVA due to a lower risk of skin cancer. * **Side Effects:** Acute (erythema, pruritus, nausea) and Chronic (Photoaging, **Squamous Cell Carcinoma**, and "PUVA lentigines"). * **Other Indications:** Vitiligo, Mycosis Fungoides (CTCL), and Alopecia Areata. * **Contraindication:** Xeroderma pigmentosum, Systemic Lupus Erythematosus (SLE), and pregnancy.

Question 20: Solar urticaria is characterized by which of the following skin reactions after exposure to the sun?

A. Stinging
B. Erythema
C. Wheal formation (Correct Answer)
D. Loss of sensation

Explanation: **Explanation:** **Solar Urticaria** is a rare form of physical urticaria triggered by exposure to ultraviolet (UV) or visible light. 1. **Why Wheal formation is correct:** The underlying pathophysiology involves a **Type I (IgE-mediated) hypersensitivity reaction**. When the skin is exposed to specific wavelengths of light, an endogenous chromophore (photoallergen) is activated. This leads to the degranulation of mast cells and the release of histamine and other inflammatory mediators. Clinically, this manifests as the rapid onset (within minutes) of **wheals** (hives), itching, and swelling, which typically resolve within 24 hours once the light source is removed. 2. **Why other options are incorrect:** * **Stinging:** While itching or burning may occur, stinging is more characteristic of *Polymorphous Light Eruption (PMLE)* or chemical photosensitivity. * **Erythema:** Although erythema (redness) often surrounds the wheal, it is a non-specific finding. The hallmark diagnostic feature of urticaria is the transient, palpable wheal. * **Loss of sensation:** This is not a feature of photodermatoses; it would suggest a neurological deficit or conditions like Leprosy. **High-Yield Clinical Pearls for NEET-PG:** * **Action Spectrum:** Most commonly triggered by **UVA** and visible light. * **Diagnosis:** Confirmed via **Phototesting**, where the skin is exposed to specific wavelengths to induce a wheal. * **Management:** First-line treatment includes **H1-antihistamines**. For refractory cases, "hardening" (photodesensitization) or Omalizumab may be used. * **Differential:** Unlike PMLE (which takes hours/days to appear), Solar Urticaria appears within **5–10 minutes** of exposure.

Question 21: A 32-year-old male presents with abdominal pain and vomiting. He also complains of psychiatric symptoms and visual hallucinations. What is the most likely diagnosis?

A. Hypothyroidism
B. Hyperthyroidism
C. Hysteria
D. Intermittent Porphyria (Correct Answer)

Explanation: ### Explanation The correct diagnosis is **Acute Intermittent Porphyria (AIP)**. This condition is an autosomal dominant metabolic disorder caused by a deficiency in the enzyme **Porphobilinogen deaminase (PBG-D)**, leading to the accumulation of porphyrin precursors like ALA and PBG. **Why it is correct:** AIP is classically characterized by the **"Triad of Ps"**: 1. **P**ain in abdomen (most common symptom, often severe and colicky). 2. **P**sychological symptoms (anxiety, agitation, hallucinations, or psychosis). 3. **P**olyneuropathy (motor weakness). The patient’s presentation of abdominal pain, vomiting, and visual hallucinations fits the classic "neurovisceral" attack of AIP. Notably, unlike other porphyrias, AIP **does not** present with cutaneous photosensitivity. **Why other options are incorrect:** * **Hypo/Hyperthyroidism:** While thyroid disorders can cause psychiatric symptoms (depression in hypo; anxiety/psychosis in hyper), they do not typically present with acute, severe abdominal pain and vomiting as the primary clinical feature. * **Hysteria:** This is a diagnosis of exclusion. Given the systemic nature of the symptoms (vomiting and abdominal pain), an organic cause like porphyria must be ruled out first. AIP is often misdiagnosed as a psychiatric disorder or a surgical emergency. **NEET-PG High-Yield Pearls:** * **Enzyme Defect:** Porphobilinogen deaminase (also known as Hydroxymethylbilane synthase). * **Urine Finding:** Urine turns **"Port-wine red"** on standing due to the oxidation of porphobilinogen to porphobilin. * **Precipitating Factors:** Barbiturates, sulfonamides, alcohol, and fasting (the "5 Ps": **P**ills, **P**upping/Pregnancy, **P**aint/Alcohol, **P**hage/Starvation, **P**eriods). * **Treatment:** Intravenous **Hemin** (suppresses ALA synthase) and high-dose glucose.

Question 22: A 26-year-old female with a history of extensive exposure to sun comes to your clinic with presentation shown below. What is the most likely diagnosis?

A. Urticaria
B. Dermatitis herpetiformis
C. Erythema marginatum
D. Dermatomyositis (Correct Answer)

Explanation: ***Dermatomyositis*** - The image shows **Gottron's papules** (violaceous, flat-topped papules over bony prominences like knuckles) or a **heliotrope rash** (periorbital violaceous rash), which are classic skin findings in dermatomyositis, an inflammatory myopathy. - The history of **sun exposure** is relevant as dermatomyositis rashes are often **photosensitive**, and the patient's age and gender are consistent with typical presentation. *Urticaria* - Urticaria presents as rapidly appearing and disappearing **wheals** (hives) that are typically itchy and erythematous with central pallor. - The lesions in the image appear more fixed and papular rather than evanescent wheals, making urticaria less likely. *Dermatitis herpetiformis* - Dermatitis herpetiformis is characterized by intensely **pruritic vesicles and bullae** symmetrically distributed on extensor surfaces, often associated with celiac disease. - The appearance in the image does not show blistering or the characteristic distribution of dermatitis herpetiformis. *Erythema marginatum* - Erythema marginatum is a rare, transient, and non-pruritic serpiginous (snake-like) rash with sharply demarcated borders and central clearing, typically seen in **acute rheumatic fever**. - The rash in the image lacks the characteristic migratory, annular, or serpiginous pattern of erythema marginatum.

Question 23: What is the best time to give oral psoralen with UVA -

A. Half an hour after UVA
B. 1 hour before UVA (Correct Answer)
C. 1 hour after UVA
D. Half hour before UVA

Explanation: ***1 hour before UVA*** - Oral psoralen, when used in **PUVA therapy**, requires adequate time for absorption and distribution to the skin to exert its photosensitizing effects. - Administering psoralen approximately **1-2 hours before UVA exposure** (typically 1.5-2 hours for 8-methoxypsoralen) ensures peak drug concentration in the skin, maximizing therapeutic efficacy. - Among the given options, **1 hour is the most appropriate timing** as it allows sufficient absorption while being closer to the therapeutic window than shorter intervals. *Half an hour after UVA* - Administering psoralen **after UVA exposure** would mean the photosensitizer is not present in sufficient concentrations during the light therapy. - This timing would render the UVA treatment largely ineffective as the primary mechanism of action, **photoreaction with UVA**, would not occur. *1 hour after UVA* - Giving psoralen **1 hour after UVA** completely misses the therapeutic window needed for the drug to photosensitize the skin during light exposure. - The UVA light would have already been administered without the active drug in the skin, thus providing **minimal to no therapeutic benefit**. *Half hour before UVA* - **Half an hour before UVA** is insufficient time for adequate oral absorption and distribution of psoralen to achieve optimal photosensitization. - This could result in **suboptimal drug concentration at the time of UVA exposure** and reduced therapeutic efficacy compared to the standard 1-2 hour pre-treatment timing.

Question 24: PUVA therapy is used in all except:

A. Psoriasis
B. Vitiligo
C. Mycosis fungoides
D. Melasma (Correct Answer)

Explanation: ***Melasma*** - **PUVA (Psoralen plus UVA) therapy** is contraindicated in melasma due to its potential to worsen hyperpigmentation and cause paradoxical darkening. - Melasma is best managed with topical agents like **hydroquinone**, **tretinoin**, and chemical peels, along with strict **sun protection**. *Psoriasis* - **PUVA therapy** is a well-established and effective treatment for moderate to severe psoriasis, especially for patients with widespread plaques. - It works by inhibiting DNA synthesis and cell proliferation in rapidly dividing keratinocytes, leading to a reduction in psoriatic lesions. *Vitiligo* - **PUVA therapy** is a common treatment for vitiligo, stimulating melanocyte activity and promoting repigmentation in affected areas. - Psoralen sensitizes melanocytes to UVA light, which then encourages melanin production. *Mycosis fungoides* - In its early stages, **mycosis fungoides**, a cutaneous T-cell lymphoma, can be effectively treated with **PUVA therapy**. - PUVA induces apoptosis of malignant T-cells in the skin, leading to remission of skin lesions.

Question 25: A sunscreen ointment has a Sun-Protection-Factor (SPF) of 15. How much UV radiation does it filter out?

A. 15%
B. 98%
C. 85%
D. 93% (Correct Answer)

Explanation: ***93%*** - An **SPF of 15** signifies that approximately **93% of UVB radiation** is filtered out by the sunscreen. - The formula to calculate the percentage of UV radiation blocked is **(1 - 1/SPF) × 100**. - For SPF 15: (1 - 1/15) × 100 = 93.33% ≈ 93% *15%* - This percentage is much too low for an SPF 15 sunscreen; it would mean the sunscreen is largely ineffective. - SPF 15 indicates a significant reduction, not just 15%, of UV radiation reaching the skin. *98%* - An **SPF of 50** typically blocks approximately 98% of UV radiation, not SPF 15. - This percentage implies a much higher level of protection than what an SPF 15 sunscreen offers. *85%* - This percentage of UV blockage is generally associated with a lower SPF value, approximately **SPF 6-7**. - An SPF of 15 provides a higher level of protection than 85%.

Question 26: Wood's lamp has a wavelength of –

A. 320 nm
B. 300 nm
C. 360 nm (Correct Answer)
D. 250 nm

Explanation: ***360 nm*** - A **Wood's lamp** emits **long-wave ultraviolet (UV-A) light**, which is typically in the range of 320 to 450 nm. - The precise wavelength of **360 nm** is the most common and effective for dermatological diagnostic applications, allowing visualization of specific fluorescence patterns. *320 nm* - While 320 nm falls within the UV-A spectrum, it is at the lower end and less characteristic of the peak emission wavelength used in Wood's lamps for diagnostic purposes. - Using this lower wavelength might result in less pronounced or absent fluorescence for some conditions. *300 nm* - A wavelength of 300 nm is in the **UV-B spectrum** which is primarily used for therapeutic purposes like **phototherapy for psoriasis**, not for diagnostic fluorescence with a Wood's lamp. - UV-B light has different biological effects and is too short to elicit the characteristic fluorescence observed with a Wood's lamp. *250 nm* - This wavelength falls into the **UV-C spectrum**, which is **germicidal** and harmful to human tissue. - UV-C light is not used in Wood's lamps for diagnostic purposes due to its damaging properties and inability to produce the desired fluorescence.

Question 27: Most common skin manifestation seen after 2 days of radiation therapy is –

A. Erythema (Correct Answer)
B. Dermatitis
C. Atopy
D. Hyperpigmentation

Explanation: ***Erythema*** - **Erythema** is the most common and earliest skin reaction to radiation therapy, typically appearing within hours to 2 weeks of treatment initiation - It results from acute vasodilation and inflammation of superficial blood vessels in response to radiation-induced cellular damage - This is the most specific and precise answer for a 2-day timeline *Dermatitis* - **Radiation dermatitis** is an umbrella term encompassing all skin reactions to radiation therapy, with erythema being its earliest manifestation - While technically erythema is a form of acute radiation dermatitis, the question asks for the most specific manifestation at 2 days, which is **erythema** - Using the general term "dermatitis" is less precise than identifying the specific initial presentation *Atopy* - **Atopy** refers to a genetic predisposition to developing allergic hypersensitivity reactions, such as eczema, asthma, and allergic rhinitis - It is not a direct consequence or skin manifestation caused by radiation therapy itself *Hyperpigmentation* - **Hyperpigmentation** is a common late skin manifestation of radiation therapy, usually appearing weeks to months after the start of treatment or following the resolution of acute inflammation - It is not typically seen within the first two days of radiation exposure

Question 28: What is the best range of UV light used for treatment of skin diseases?

A. 100 – 200 nm
B. > 700 nm
C. 400 – 700 nm
D. 200 – 400 nm (Correct Answer)

Explanation: ***200 – 400 nm*** - This range encompasses **UVA (320-400 nm)** and **UVB (290-320 nm)**, which are the most commonly used portions of the **UV spectrum** for treating various skin conditions like psoriasis and eczema. - Specifically, **narrowband UVB (311-313 nm)** is highly effective due to its therapeutic benefits with reduced side effects compared to broadband UVB or UVA. *100 – 200 nm* - This range falls into the **vacuum UV (VUV)** spectrum, which is largely absorbed by air and is not practical for dermatological phototherapy due to its limited penetration and potential for significant cellular damage. - It is known for its germicidal properties but is not used for treating skin diseases in living tissue due to its **high energy** and **low penetration** depth. *> 700 nm* - Wavelengths above 700 nm fall into the **infrared (IR) spectrum** or visible light, which primarily produces heat and has different therapeutic applications. - While IR light can be used for therapies like **pain relief** and **wound healing**, it does not have the immunomodulatory effects on skin cells needed for conditions traditionally treated by UV. *400 – 700 nm* - This range represents the **visible light spectrum**, which is used in some dermatological treatments like **photodynamic therapy (PDT)** or for certain **pigmentary disorders**. - However, visible light does not possess the same **immunomodulatory** and **antiproliferative effects** on keratinocytes and T-cells that make UV light effective for conditions like psoriasis.

Question 29: Most common acute skin manifestation of radiotherapy:

A. Dermatitis
B. Erythema (Correct Answer)
C. Atopy
D. Hyperpigmentation

Explanation: ***Erythema*** - **Erythema** (redness) is the most immediate and common acute cutaneous reaction to radiotherapy due to **vasodilation** and inflammation of the skin in the irradiated area. - It often appears within days to weeks of starting radiation treatment and is a direct consequence of cell damage and the body's inflammatory response to it. *Dermatitis* - While radiation dermatitis is a broader term encompassing various skin changes from radiotherapy, **erythema** is the initial and most prevalent component of this dermatological spectrum, making it a more specific answer for the "most common" manifestation. - Dermatitis can also include later-stage problems like **dry desquamation** and **moist desquamation**, which are more severe reactions. *Atopy* - **Atopy** refers to a genetic predisposition to develop allergic diseases like asthma, allergic rhinitis, or atopic dermatitis. - It is an **intrinsic immune predisposition** and not a direct skin manifestation caused by radiotherapy itself. *Hyperpigmentation* - While **hyperpigmentation** can occur in the irradiated area, it is typically a **subacute or chronic** reaction, often appearing weeks to months after the onset of erythema or after the completion of treatment. - It is not the most immediate or common acute manifestation compared to erythema.

Question 30: Methoxysalen is used as:

A. Photoprotective agent
B. Used in photochemotherapy (Correct Answer)
C. Melanising agent
D. Depigmenting agent

Explanation: ***Used in photochemotherapy*** - **Methoxysalen** is a **psoralen derivative** that becomes activated by ultraviolet A (UVA) light. - This activation allows it to form **photoadducts with DNA**, inhibiting cell proliferation, which is the basis for its use in **photochemotherapy** for conditions like psoriasis and vitiligo. *Photoprotective agent* - **Photoprotective agents** like sunscreens work by **reflecting or absorbing UV radiation** to prevent skin damage. - **Methoxysalen** actually **sensitizes the skin to UV light**, increasing its effects rather than blocking them. *Melanising agent* - While methoxysalen can induce repigmentation in conditions like vitiligo, it does so by increasing the skin's sensitivity to UV light, which then stimulates **melanogenesis**. - It is not a direct melanising agent that independently promotes melanin production without UV exposure. *Depigmenting agent* - **Depigmenting agents** aim to reduce or remove melanin from the skin, often used for hyperpigmentation disorders. - **Methoxysalen**, especially when used in PUVA therapy, helps to **re-pigment** areas affected by conditions like vitiligo, making it the opposite of a depigmenting agent.

Question 31: A patient develops localized blisters after UV exposure. Which porphyria is most likely?

A. Acute intermittent porphyria
B. Porphyria cutanea tarda (Correct Answer)
C. Erythropoietic protoporphyria
D. Congenital erythropoietic porphyria

Explanation: ***Porphyria cutanea tarda*** - This is the **most common porphyria** and is classically characterized by **photosensitivity** leading to **vesicles and bullae** (blisters), skin fragility, and hyperpigmentation in sun-exposed areas (particularly dorsum of hands). - The localized blisters after UV exposure are a hallmark sign, resulting from the accumulation of **uroporphyrins** in the skin, which are activated by UV light (400-410 nm wavelength). - Associated with hepatic dysfunction, alcohol use, hepatitis C, estrogen use, and hemochromatosis. *Acute intermittent porphyria* - Primarily causes **neurovisceral symptoms** such as acute abdominal pain, psychiatric disturbances, and neurological deficits. - It typically **does not present with cutaneous manifestations** or photosensitivity. - This is a hepatic porphyria without skin involvement. *Erythropoietic protoporphyria* - Characterized by **immediate painful photosensitivity** that manifests as burning, stinging, and itching within minutes of sun exposure. - Presents with **erythema and edema** but typically **no vesicles or bullae** - this is the key differentiating feature from PCT. - Patients experience acute pain and may develop petechiae, but distinct localized blisters are not characteristic. - Long-term exposure can lead to waxy scarring and thickened skin. *Congenital erythropoietic porphyria* - Also known as **Günther's disease**, this is a very rare and severe porphyria presenting in infancy or early childhood. - It causes severe photosensitivity with **vesicles, bullae, and mutilating scarring**, as well as **hemolytic anemia** and **reddish urine and teeth (erythrodontia)**. - The early onset, severity, and systemic features distinguish it from PCT in adults.

Question 32: A 45-year-old woman with poorly controlled type 2 diabetes (HbA1c 9.2%) and chronic kidney disease presents with intensely pruritic nodules on extensor surfaces for 8 months. Previous treatments with topical steroids, antihistamines, and gabapentin provided minimal relief. Skin biopsy shows acanthosis, compact orthokeratosis, and increased nerve fibers. CBC shows eosinophilia. Most appropriate next step is:

A. Initiate dupilumab (Correct Answer)
B. Begin phototherapy
C. Start oral cyclosporine
D. Trial of oral doxepin

Explanation: ***Initiate dupilumab*** - **Dupilumab** was FDA-approved for **prurigo nodularis** in September 2022 and is now considered **first-line systemic therapy** for moderate-to-severe cases refractory to topical treatments. - Phase 3 trials (PRIME, PRIME2) demonstrated **significant improvement in pruritus** (>50% reduction in itch scores) and **lesion clearance** in patients with prurigo nodularis. - **Excellent safety profile** in patients with **chronic kidney disease** and **diabetes** - no dose adjustment needed for CKD, and does not worsen glycemic control or renal function. - As a **targeted biologic** (IL-4/IL-13 inhibitor), it addresses the underlying type 2 inflammation in prurigo nodularis with minimal systemic adverse effects. - Given this patient's **failure of multiple prior therapies** and **severe comorbidities**, dupilumab is the most appropriate next step. *Incorrect: Begin phototherapy* - While **narrowband UVB phototherapy** is effective for prurigo nodularis, it is typically considered **second-line or adjunctive therapy** rather than first-line systemic treatment for severe refractory cases. - Requires **multiple weekly visits** (2-3 times per week initially), which may be challenging for patients with significant comorbidities. - In the current era with FDA-approved biologics for prurigo nodularis, phototherapy is often reserved for patients who cannot access or have failed biologic therapy. *Incorrect: Start oral cyclosporine* - Oral cyclosporine carries significant risks of **nephrotoxicity** and **hyperglycemia**, which would be especially problematic in a patient with pre-existing **chronic kidney disease** and **poorly controlled diabetes** (HbA1c 9.2%). - While it can be effective for severe prurigo nodularis, the risk-benefit ratio is unfavorable in this clinical context given safer alternatives. - Requires frequent monitoring of renal function and blood pressure. *Incorrect: Trial of oral doxepin* - Oral doxepin, a **tricyclic antidepressant with H1/H2 antihistaminic properties**, can help with chronic pruritus but is typically less effective for **nodular lesions**. - Causes significant **sedation** and anticholinergic side effects, which may not be well-tolerated. - Given that standard antihistamines and gabapentin have already failed, and considering the **severity and chronicity** of symptoms (8 months, intensely pruritic nodules), a more potent targeted therapy is warranted.

Question 33: A 45-year-old male with hepatitis C presents with photosensitivity, blisters, and hypertrichosis. Laboratory results show increased serum porphyrins. What is the likely diagnosis?

A. Porphyria cutanea tarda; phlebotomy + hydroxychloroquine (Correct Answer)
B. Polycythemia vera; high-dose steroids
C. Lichen planus; topical steroids, oral retinoids
D. Dermatitis herpetiformis; gluten-free diet + dapsone

Explanation: ***Porphyria cutanea tarda; phlebotomy + hydroxychloroquine*** - **Porphyria cutanea tarda (PCT)** is strongly suggested by the triad of **photosensitivity**, **blisters**, and **hypertrichosis**, especially in a patient with **hepatitis C**. - **Increased serum porphyrins** confirm the diagnosis, and **phlebotomy** (to reduce iron overload) and **hydroxychloroquine** (to reduce porphyrin accumulation) are established treatments. *Polycythemia vera; high-dose steroids* - **Polycythemia vera** is a myeloproliferative disorder characterized by an overproduction of red blood cells, not skin lesions, photosensitivity, or increased porphyrins. - **High-dose steroids** are not a primary treatment for polycythemia vera; **phlebotomy** and **hydroxyurea** are common therapies. *Lichen planus; topical steroids, oral retinoids* - **Lichen planus** presents with **pruritic, purple, polygonal papules** often on the wrists, ankles, and oral mucosa, which does not match the described symptoms. - While **topical steroids** are used for lichen planus, it does not involve photosensitivity, blisters, or abnormal porphyrin levels. *Dermatitis herpetiformis; gluten-free diet + dapsone* - **Dermatitis herpetiformis** typically presents as intensely **pruritic vesicles and bullae** on extensor surfaces, strongly associated with **celiac disease**. - There is no mention of gut symptoms or an association with hepatitis C, and the primary treatment involves a **gluten-free diet** and **dapsone**.

Question 34: A 30-year-old woman presents with blistering on her hands after sun exposure. She has a history of alcohol use disorder. Laboratory tests show elevated liver enzymes and low serum haptoglobin. Analyze the clinical scenario to identify the most likely diagnosis.

A. Porphyria cutanea tarda (Correct Answer)
B. Pemphigus vulgaris (PV)
C. Dermatitis herpetiformis (DH)
D. Systemic lupus erythematosus (SLE)

Explanation: ***Porphyria cutanea tarda*** - **Blistering on sun-exposed areas** (hands) and a history of **alcohol use disorder** are classic presentations of PCT. - **Elevated liver enzymes** support the diagnosis, as PCT is strongly associated with liver disease, alcohol use, hepatitis C, and iron overload. - PCT is the most common porphyria and results from deficiency of uroporphyrinogen decarboxylase (UROD), leading to accumulation of photosensitizing porphyrins in the skin. *Pemphigus vulgaris (PV)* - Presents with **flaccid blisters** and erosions primarily affecting the **mucous membranes** and skin, often without a strong association with sun exposure. - Diagnosis is confirmed by **direct immunofluorescence** showing anti-desmoglein antibodies, and generally not associated with liver enzyme abnormalities or alcohol use. *Dermatitis herpetiformis (DH)* - Characterized by **intensely pruritic vesicles** and papules, mainly on extensor surfaces (elbows, knees, buttocks), strongly associated with **celiac disease** and gluten sensitivity. - While it is a blistering disease, sun exposure is not a primary trigger, nor are liver enzyme abnormalities or alcohol use typical associations. *Systemic lupus erythematosus (SLE)* - Photosensitivity can cause skin lesions, but typically presents as a **malar rash** or discoid lesions, not vesiculobullous eruptions. - It is a systemic autoimmune disease with diverse manifestations, but **blistering due to sun exposure** as the primary finding is not characteristic of SLE.

Question 35: A 50-year-old male with a history of liver disease presents with a photosensitive, blistering rash on his hands. What is the most likely diagnosis?

A. Porphyria cutanea tarda (Correct Answer)
B. Herpes simplex
C. Bullous pemphigoid
D. Pemphigus vulgaris

Explanation: ***Porphyria cutanea tarda*** - The classic triad of **photosensitive blistering on sun-exposed areas** (especially dorsal hands), **fragile skin**, and **association with liver disease** makes PCT the most likely diagnosis. - Caused by deficiency of **uroporphyrinogen decarboxylase**, leading to accumulation of photoreactive porphyrins in the skin. - Strong associations include **hepatitis C, alcohol-related liver disease, hemochromatosis**, and estrogen use. - Characteristic findings: vesicles, bullae, erosions, milia, and hyperpigmentation on sun-exposed areas. *Herpes simplex* - Presents as **grouped vesicles on an erythematous base**, often with prodrome of tingling or burning. - Not characteristically photosensitive and **no association with liver disease**. - Lesions are typically recurrent in the same location and resolve with crusting. *Bullous pemphigoid* - An **autoimmune subepidermal blistering disease** with tense bullae and intense pruritus. - Typically affects elderly patients but **not associated with photosensitivity or liver disease**. - Blisters can occur on any body site, not specifically sun-exposed areas. *Pemphigus vulgaris* - An **autoimmune intraepidermal blistering disease** with flaccid bullae that easily rupture, leaving painful erosions. - Often involves **mucous membranes** (oral cavity most common). - **No association with photosensitivity or liver disease**.

Question 36: A 20-year-old woman presents with pruritic, erythematous, scaly lesions on her face and neck that worsen with sun exposure. What is the most likely diagnosis?

A. Systemic lupus erythematosus
B. Rosacea
C. Polymorphous light eruption (PMLE) (Correct Answer)
D. Seborrheic dermatitis

Explanation: ***Polymorphous light eruption (PMLE)*** - PMLE is the **most common photodermatosis**, typically affecting young women in their 20s-40s, perfectly matching this patient's demographic. - Presents with **pruritic, erythematous papules, plaques, or vesicles** on **sun-exposed areas** (face, neck, décolletage, arms) that appear or worsen after sun exposure. - Lesions typically develop within **hours to days** after sun exposure and may have a scaly appearance, directly aligning with the clinical presentation. - The condition is more common in **spring/early summer** when sun exposure increases after winter months. *Systemic lupus erythematosus* - While **photosensitivity** is a feature of SLE, the classic rash is a **malar (butterfly) rash** or discoid lesions with a different morphology. - SLE typically presents with **systemic symptoms** such as arthralgia, fatigue, fever, or kidney involvement, which are not mentioned here. - SLE is less common than PMLE and would require additional clinical and serological evidence (ANA, anti-dsDNA). *Rosacea* - Rosacea typically presents with **facial erythema, telangiectasias, papules, and pustules** on the central face (cheeks, nose, chin, forehead). - While sun exposure can trigger flares, **significant pruritus and scaling** are not characteristic features of rosacea. - Rosacea does not typically extend to the neck and lacks the acute photosensitive pattern seen here. *Seborrheic dermatitis* - Characterized by **erythematous patches with greasy, yellowish scales** in sebum-rich areas (scalp, eyebrows, nasolabial folds, chest). - **Not exacerbated by sun exposure**—this is the key differentiating feature from photodermatoses. - While it can affect the face, the relationship to sun exposure and the distribution pattern favor PMLE.

Question 37: A 12-year-old boy develops pruritic hemorrhagic vesicles on his cheeks, ears, nose, and hands 12 hours after spending his holiday at Kovalam beach. A week later, the lesions crusted and healed with permanent scars. What is the most probable diagnosis?

A. Dermatitis herpetiformis
B. Pityriasis rosea
C. Pityriasis rubra pilaris
D. Phytophotodermatitis (Correct Answer)

Explanation: ***Phytophotodermatitis*** - This condition occurs when **skin comes into contact with photosensitizing plant compounds (furocoumarins)** and is then exposed to **UVA light**, leading to a phototoxic reaction. - The presentation of **pruritic hemorrhagic vesicles** on sun-exposed areas (cheeks, ears, nose, hands) after beach exposure, followed by scabbing and **permanent scarring**, is classic for phytophotodermatitis. *Pityriasis rosea* - Characterized by an **initial "herald patch"** followed by smaller, oval, pinkish-red patches with fine scales, often arranged in a **"Christmas tree" pattern** on the trunk. - It is typically **self-limiting**, does not involve hemorrhagic vesicles or scarring, and is not directly triggered by sun exposure. *Pityriasis rubra pilaris* - A chronic condition characterized by **follicular papules** that coalesce into **reddish-orange plaques** with islands of normal skin, often starting on the scalp, neck, and upper trunk. - It does not present with acute hemorrhagic vesicles or follow sun exposure in this manner, and scarring is not a typical outcome. *Dermatitis herpetiformis* - An intensely itchy, chronic blistering skin condition associated with **gluten-sensitive enteropathy (celiac disease)**, characterized by symmetrically distributed papulovesicular lesions, often on the elbows, knees, buttocks, and scalp. - While it involves pruritic vesicles, the hemorrhagic nature, specific distribution following sun exposure, and subsequent scarring do not align with dermatitis herpetiformis.

Question 38: In which of the following conditions is phototherapy, specifically ultraviolet light therapy, useful for treatment?

A. Psoriasis (Correct Answer)
B. Tinea corporis
C. Pemphigus
D. PMLE

Explanation: ***Psoriasis*** - **Phototherapy** (narrowband UVB, broadband UVB, or PUVA) is a **well-established first-line treatment** for **moderate-to-severe psoriasis**. - It works by **suppressing overactive immune cells** in the skin, reducing inflammation and decreasing keratinocyte proliferation. - **Direct therapeutic effect** on active psoriatic lesions makes this the primary indication for phototherapy in dermatology. *Tinea corporis* - **Tinea corporis** is a **superficial fungal infection** (dermatophytosis) of the skin. - Requires **antifungal medications** (topical azoles or oral terbinafine/griseofulvin) for treatment. - **Phototherapy has no antifungal activity** and is not used for this condition. *Pemphigus* - **Pemphigus** is an **autoimmune blistering disease** with intraepidermal acantholysis. - Treatment requires **systemic immunosuppression** (corticosteroids, rituximab, azathioprine). - **Phototherapy is not indicated** and could potentially worsen the condition. *PMLE* - **Polymorphous light eruption (PMLE)** is a common **photosensitivity disorder**. - While **prophylactic photohardening** (gradual controlled UV exposure) can be used to build tolerance **before sun exposure season**, this is a **preventative desensitization strategy**, not treatment of active disease. - Unlike psoriasis, phototherapy does **not treat active PMLE lesions** and can trigger flares if not done properly. - The primary approach for active PMLE is **sun avoidance, sun protection, and topical corticosteroids**.

Question 39: Which of the following statements about actinic lichen planus is false?

A. Associated with severe pruritus (Correct Answer)
B. Violaceous brown papules
C. Usually affects exposed areas of body
D. Autoimmune etiology

Explanation: ***Associated with severe pruritus*** - While other forms of lichen planus, especially the typical cutaneous type, are often associated with **severe pruritus**, actinic lichen planus is typically characterized by **mild or absent pruritus**. - Its presentation is often more focused on pigmentary changes and papules in sun-exposed areas rather than intense itching. *Autoimmune etiology* - **Lichen planus**, including its actinic variant, is recognized as an **autoimmune disease**. - It involves a **T-cell-mediated immune response** against basal keratinocytes. *Violaceous brown papules* - Actinic lichen planus commonly presents with **violaceous, brown, or hyperpigmented papules and plaques**. - These lesions often exhibit a subtle **annular or reticulated pattern**. *Usually affects exposed areas of body* - As its name suggests ("actinic" referring to light), this variant of lichen planus preferentially affects **sun-exposed areas** such as the face, neck, and dorsal hands. - This distribution distinguishes it from classic lichen planus, which can occur anywhere but often affects the flexor surfaces of the wrists, ankles, and oral mucosa.

Question 40: What is the primary purpose of UV rays examination in dermatology?

A. Assessing pigmentary disorders (Correct Answer)
B. Detecting porphyria
C. Diagnosing fungal infections
D. Detecting bacterial infections

Explanation: ***Assessing pigmentary disorders*** - **UV light** (specifically **Wood's lamp** examination) enhances the contrast between pigmented and non-pigmented areas of the skin, making **vitiligo**, **melasma**, and other **pigmentary changes** more apparent. - This increased visibility allows for better delineation of lesion borders and estimation of the extent of pigmentary abnormalities, aiding in diagnosis and treatment planning. - This is the **most common and primary clinical application** of Wood's lamp in dermatology. *Diagnosing fungal infections* - While a **Wood's lamp** can sometimes highlight certain fungal infections like **tinea capitis** caused by **Microsporum species** (due to **fluorescence**), it is not the primary or definitive diagnostic tool. - **Microscopy with KOH prep** and **fungal culture** are the gold standard for diagnosing fungal infections. - Most modern dermatophytes do not fluoresce, limiting its utility. *Detecting porphyria* - Certain types of **porphyria** (e.g., **porphyria cutanea tarda**) can cause **red-pink fluorescence of urine** or teeth under **UV light**, but this is a systemic finding, not a primary dermatological examination purpose. - Diagnosis of **porphyria** primarily relies on **laboratory tests** measuring porphyrin levels in blood, urine, and stool. *Detecting bacterial infections* - While certain bacteria (such as **Corynebacterium minutissimum** causing **erythrasma**) show **coral-red fluorescence** under Wood's lamp, this is a specific diagnostic application, not the primary purpose. - Most bacterial skin infections do not fluoresce, and culture/clinical examination remain the primary diagnostic methods.

Question 41: Which type of ultraviolet radiation causes the most skin disorders?

A. UV-A
B. UV-B (Correct Answer)
C. UV-C
D. None of the options

Explanation: ***UV-B*** - **UV-B radiation** is a major cause of **sunburn** and directly damages DNA, leading to most **skin cancers** (basal cell carcinoma, squamous cell carcinoma, and melanoma). - It plays a significant role in photoaging and the development of most **skin disorders** related to sun exposure. *UV-A* - **UV-A radiation** penetrates deeper into the skin than UV-B and is primarily associated with **photoaging**, producing wrinkles and fine lines. - While it contributes to skin cancer development, its direct role in DNA damage and sunburn is less than that of UV-B. *UV-C* - **UV-C radiation** is the most damaging type of UV light, but it is almost entirely **absorbed by the Earth's ozone layer** and does not reach the Earth's surface. - Therefore, it does not typically cause skin disorders in humans under natural conditions. *None of the options* - This option is incorrect because **UV-B radiation** is well-established as a primary cause of numerous skin disorders, including most skin cancers and sunburn.

Question 42: What is the wavelength of the light emitted by a Wood's lamp?

A. 365 nm (Correct Answer)
B. 400 nm
C. 320 nm
D. 200 nm

Explanation: ***365 nm*** - A Wood's lamp primarily emits **long-wave ultraviolet A (UVA)** light, which has a wavelength of approximately **365 nanometers (nm)**. - This specific wavelength is crucial for inducing **fluorescence** in various substances, including certain dermatological conditions and infections. *400 nm* - A wavelength of **400 nm** falls into the visible light spectrum (violet), which is not the primary emission of a Wood's lamp. - While some visible light may be present, it does not produce the characteristic diagnostic fluorescence seen with UVA. *320 nm* - **320 nm** falls within the **UVB range**, which is a shorter wavelength than the UVA emitted by a Wood's lamp. - UVB light is associated with different biological effects and is not typically used for diagnostic fluorescence in the same way UVA is. *200 nm* - A wavelength of **200 nm** is in the **UVC range**, which is highly energetic and largely absorbed by the Earth's ozone layer. - UVC is germicidal and damaging to biological tissues, and it is not safe or practical for diagnostic applications like a Wood's lamp, which requires longer UVA wavelengths.

Question 43: Exposure to sunlight can precipitate chronic disc-shaped skin lesions characteristic of which of the following conditions?

A. Dermatitis herpetiformis
B. Lupus vulgaris
C. Chloasma
D. Discoid lupus erythematosus (Correct Answer)

Explanation: ***Discoid lupus erythematosus*** - This condition is a **chronic cutaneous form of lupus** characterized by distinctive **disc-shaped lesions**, often on sun-exposed areas. - **Photosensitivity** is a prominent feature, meaning sunlight direct exposure often **exacerbates or triggers these lesions**. *Chloasma* - This refers to **melasma**, a common condition causing **dark, discolored patches** on the skin, often triggered by **hormonal changes** (e.g., pregnancy) and sun exposure. It does not typically form disc-shaped lesions. - While sunlight exposure influences its presentation, it lacks the characteristic **inflammatory disc-shaped lesions** of discoid lupus. *Dermatitis herpetiformis* - This is an **autoimmune blistering skin condition** strongly associated with **celiac disease**, characterized by intensely pruritic papules and vesicles, not disc-shaped lesions. - Its lesions are **itchy, erythematous papules and vesicles** that are symmetrically distributed, and it is not directly precipitated by sunlight exposure. *Lupus vulgaris* - This is a form of **cutaneous tuberculosis** presenting as slowly progressive, ulcerative, and destructive skin lesions. It is caused by **Mycobacterium tuberculosis** and is unrelated to sun exposure. - It involves direct **tuberculous infection of the skin**, and its clinical presentation differs significantly from the autoimmune, photosensitivity-driven lesions of discoid lupus erythematosus.

Question 44: What is the optimal wavelength of light emitted by a Wood's lamp for dermatological examinations?

A. 365 nm (Correct Answer)
B. 400 nm
C. 320 nm
D. 200 nm

Explanation: **365 nm** - A Wood's lamp primarily emits **long-wave UVA light** in the 320 to 400 nm range, with an optimal peak around **365 nm**. - This specific wavelength is ideal for inducing **fluorescence** in various dermatological conditions, making them visible. *400 nm* - While within the UVA range, **400 nm** is at the higher end and may not provide the optimal fluorescence yield for all diagnostic purposes compared to 365 nm. - Light at 400 nm is closer to the visible light spectrum and might offer less distinction for subtle fluorescence. *320 nm* - **320 nm** is at the lower end of the UVA spectrum, bordering on UVB. - While still capable of inducing some fluorescence, it is generally less effective than 365 nm for the conditions typically examined with a Wood's lamp. *200 nm* - **200 nm** falls into the **UVC range** (100-280 nm), which is harmful and not used for diagnostic purposes in a Wood's lamp. - This wavelength is absorbed by the atmosphere and epidermis and can cause significant **DNA damage**, making it unsafe for routine dermatological examination.

Practice by Chapter

Fundamentals of Photobiology

Practice Questions

UVA and UVB Phototherapy

Practice Questions

PUVA Therapy

Practice Questions

Narrow-Band UVB Therapy

Practice Questions

Excimer Laser Therapy

Practice Questions

Photodynamic Therapy

Practice Questions

Phototoxicity and Photoallergy

Practice Questions

Photoprotection

Practice Questions

Sunscreens

Practice Questions

Photoaging

Practice Questions

Phototherapy Protocols

Practice Questions

Management of Phototherapy Side Effects

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free